JP2010506932A - 結晶性の無水ドセタキセルの製造方法 - Google Patents

結晶性の無水ドセタキセルの製造方法 Download PDF

Info

Publication number
JP2010506932A
JP2010506932A JP2009533389A JP2009533389A JP2010506932A JP 2010506932 A JP2010506932 A JP 2010506932A JP 2009533389 A JP2009533389 A JP 2009533389A JP 2009533389 A JP2009533389 A JP 2009533389A JP 2010506932 A JP2010506932 A JP 2010506932A
Authority
JP
Japan
Prior art keywords
debenzoyl
butoxycarbonyl
tert
docetaxel
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009533389A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506932A5 (cg-RX-API-DMAC7.html
Inventor
リャオ,ユエン−シュー
ホー,メン−フェン
チェン,シュー−ピン
リン,チア−ニン
リン,ユー−リ
シャオ,ツン−ユー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scinopharm Singapore Pte Ltd
Original Assignee
Scinopharm Singapore Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Singapore Pte Ltd filed Critical Scinopharm Singapore Pte Ltd
Publication of JP2010506932A publication Critical patent/JP2010506932A/ja
Publication of JP2010506932A5 publication Critical patent/JP2010506932A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
JP2009533389A 2006-10-20 2007-10-19 結晶性の無水ドセタキセルの製造方法 Pending JP2010506932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85334106P 2006-10-20 2006-10-20
PCT/US2007/022309 WO2008051465A2 (en) 2006-10-20 2007-10-19 Process for making crystalline anhydrous docetaxel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013087629A Division JP2013155191A (ja) 2006-10-20 2013-04-18 結晶性の無水ドセタキセルの製造方法

Publications (2)

Publication Number Publication Date
JP2010506932A true JP2010506932A (ja) 2010-03-04
JP2010506932A5 JP2010506932A5 (cg-RX-API-DMAC7.html) 2010-11-25

Family

ID=39325127

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009533389A Pending JP2010506932A (ja) 2006-10-20 2007-10-19 結晶性の無水ドセタキセルの製造方法
JP2013087629A Pending JP2013155191A (ja) 2006-10-20 2013-04-18 結晶性の無水ドセタキセルの製造方法
JP2014233275A Pending JP2015057423A (ja) 2006-10-20 2014-11-18 無水ドセタキセルの製造方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013087629A Pending JP2013155191A (ja) 2006-10-20 2013-04-18 結晶性の無水ドセタキセルの製造方法
JP2014233275A Pending JP2015057423A (ja) 2006-10-20 2014-11-18 無水ドセタキセルの製造方法

Country Status (10)

Country Link
US (2) US7662980B2 (cg-RX-API-DMAC7.html)
EP (2) EP2330101A1 (cg-RX-API-DMAC7.html)
JP (3) JP2010506932A (cg-RX-API-DMAC7.html)
KR (1) KR101266549B1 (cg-RX-API-DMAC7.html)
CN (1) CN101534642A (cg-RX-API-DMAC7.html)
AR (1) AR063347A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007309534B2 (cg-RX-API-DMAC7.html)
CA (2) CA2667416C (cg-RX-API-DMAC7.html)
NZ (1) NZ576355A (cg-RX-API-DMAC7.html)
WO (1) WO2008051465A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019055989A (ja) * 2013-10-23 2019-04-11 インデナ エッセ ピ ア カバジタキセルの結晶性無水和物形態、その調製方法ならびにその医薬組成物

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
CA2653541C (en) 2005-06-06 2014-12-23 The University Of British Columbia Polymer-based serum albumin substitute
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
KR100878455B1 (ko) * 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
WO2009006590A2 (en) * 2007-07-04 2009-01-08 Dr. Reddy's Laboratories Ltd. Docetaxel process and polymorphs
WO2010059916A2 (en) * 2008-11-20 2010-05-27 Dr. Reddy's Laboratories Ltd. Preparation of docetaxel
PL388144A1 (pl) * 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
US8686165B2 (en) * 2009-11-04 2014-04-01 Emcure Pharmaceuticals Limited Process for preparation of taxane derivatives
KR101149600B1 (ko) * 2009-12-31 2012-05-29 주식회사 삼양제넥스바이오 고순도 무수결정형 도세탁셀 제조방법
EP2542613A4 (en) 2010-03-01 2013-12-11 Univ British Columbia SUBSTITUTED HYPERBRANCHED POLYGLYCEROLS
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
EP2447268A1 (en) 2010-10-29 2012-05-02 INDENA S.p.A. Crystalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III
KR20120096200A (ko) * 2011-02-22 2012-08-30 동아제약주식회사 결정형 도세탁셀 및 이의 제조방법
WO2012131698A1 (en) * 2011-04-01 2012-10-04 Shilpa Medicare Limited Process for preparing docetaxel and its hydrate
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
WO2012160568A1 (en) * 2011-05-23 2012-11-29 Shilpa Medicare Limited Process for preparing docetaxel trihydrate polymorph
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
KR101508302B1 (ko) * 2013-06-10 2015-04-06 숭실대학교산학협력단 초음파를 이용한 도세탁셀 수화물 제조방법
CN107683134B (zh) 2015-05-15 2021-02-23 珠海贝海生物技术有限公司 多西他赛及人血清白蛋白复合物
CN115487312B (zh) 2016-10-27 2025-02-07 珠海贝海生物技术有限公司 多西他赛和人血清白蛋白的中性pH组合物
CN109836401B (zh) * 2017-11-28 2023-02-14 正大天晴药业集团股份有限公司 一种多西他赛的纯化方法
JP7734677B2 (ja) 2020-02-04 2025-09-05 珠海貝海生物技術有限公司 ドセタキセル製剤
CN111718316A (zh) * 2020-07-02 2020-09-29 无锡紫杉药业有限公司 一种三水多西他赛生产工艺
AU2022443487B2 (en) 2022-02-25 2026-05-21 Zhuhai Beihai Biotech Co., Ltd. Taxotere composition and method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791983A (en) * 1980-10-01 1982-06-08 Glaxo Group Ltd Ranitidine, manufacture and medicinal composition containing same
JPH06192228A (ja) * 1992-10-19 1994-07-12 Bayer Ag 結晶性(r)−(−)−2−シクロヘプチル−n−メチルスルフオニル−[4−(2−キノリニルメトキシ)−フエニル]−アセトアミド
JPH0753581A (ja) * 1993-06-07 1995-02-28 Takeda Chem Ind Ltd 結晶質l−アスコルビン酸−2−燐酸エステルマグネシウム塩の製造法
WO2005061474A1 (en) * 2003-12-12 2005-07-07 Quiral Química Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2703049B1 (fr) * 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis
US5917062A (en) * 1997-11-21 1999-06-29 Indena S.P.A Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
US6531611B2 (en) 2001-03-23 2003-03-11 Scinopharm Taiwan, Ltd. Process for making taxane derivatives
US6881852B2 (en) 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
DE60323079D1 (de) 2002-04-05 2008-10-02 Natural Pharmaceuticals Inc Umwandlung von taxanmolekülen
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US6956123B2 (en) 2003-03-17 2005-10-18 Natural Pharmaccuticals, Inc. Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
WO2005061747A1 (ja) 2003-12-19 2005-07-07 Daido Steel Co.,Ltd 耐溶損性に優れた熱間工具鋼及び金型部材
WO2007044950A2 (en) * 2005-10-12 2007-04-19 Sicor, Inc. Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) * 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
KR20080100264A (ko) 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791983A (en) * 1980-10-01 1982-06-08 Glaxo Group Ltd Ranitidine, manufacture and medicinal composition containing same
JPH06192228A (ja) * 1992-10-19 1994-07-12 Bayer Ag 結晶性(r)−(−)−2−シクロヘプチル−n−メチルスルフオニル−[4−(2−キノリニルメトキシ)−フエニル]−アセトアミド
JPH0753581A (ja) * 1993-06-07 1995-02-28 Takeda Chem Ind Ltd 結晶質l−アスコルビン酸−2−燐酸エステルマグネシウム塩の製造法
WO2005061474A1 (en) * 2003-12-12 2005-07-07 Quiral Química Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN5007022380; ZASKE L: JOURNAL DE PHYSIQUE IV V11, 2001, P221-226, EDITIONS DE PHYSIQUE. *
JPN6009055961; 医薬審第307号 , 19980330 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019055989A (ja) * 2013-10-23 2019-04-11 インデナ エッセ ピ ア カバジタキセルの結晶性無水和物形態、その調製方法ならびにその医薬組成物

Also Published As

Publication number Publication date
WO2008051465A2 (en) 2008-05-02
EP2094084A2 (en) 2009-09-02
JP2013155191A (ja) 2013-08-15
KR20090080986A (ko) 2009-07-27
AU2007309534A1 (en) 2008-05-02
JP2015057423A (ja) 2015-03-26
US20080108693A1 (en) 2008-05-08
AU2007309534B2 (en) 2012-08-16
CA2667416A1 (en) 2008-05-02
CA2667416C (en) 2013-12-17
WO2008051465A3 (en) 2009-04-16
EP2330101A1 (en) 2011-06-08
CA2756603A1 (en) 2008-05-02
KR101266549B1 (ko) 2013-05-24
EP2094084A4 (en) 2010-01-13
AR063347A1 (es) 2009-01-21
NZ576355A (en) 2012-04-27
US7662980B2 (en) 2010-02-16
CA2756603C (en) 2013-05-28
CN101534642A (zh) 2009-09-16
US8357811B2 (en) 2013-01-22
US20090275762A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
JP2015057423A (ja) 無水ドセタキセルの製造方法
JP5593342B2 (ja) ドセタキセルの製造方法
HU215839B (hu) Új, furil- és tienil-csoporttal szubsztituált taxánszármazékok és hatóanyagként ilyen vegyületeket tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra
JP2011137045A (ja) 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2002505326A (ja) 強塩基と求電子を用いる、7−ヒドロキシルの保護によるバッカチンiiiからのパクリタキセルの合成
JP2010513267A (ja) ドセタキセルの製造方法及びそれに用いられる中間体
DE69503213T2 (de) Baccatin-Derivate und Verfahren zu deren Herstellung
KR100921036B1 (ko) 탁산유도체의 제조방법 및 이에 사용되는 중간체
AU2012203862B2 (en) Process for making docetaxel trihydrate
CN107778271B (zh) 抗癌化合物cx1409的合成方法
JP5870197B2 (ja) タキサン誘導体の製造方法
KR20260057472A (ko) 링커-약물 제조 방법
HK1135102A (en) Method of preparing docetaxel and intermediates used therein
HK1135104A (en) Method of preparing taxane derivatives and intermediates used therein

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130625